Author

Diana Lin

Primary ORCID profile (0000-0001-9645-3247 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Diana LiniD1 paper · BC Cancer Agency

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Alexandra SchureriD· 1 shared Aly KarsaniD· 1 shared Amber LouwagieiD· 1 shared Brenda Ma· 1 shared Christopher C. OakesiD· 1 shared Debajeet GhoshiD· 1 shared Fabiana PernaiD· 1 shared Fiona Wong· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexandra SchurerORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

LncRNA-mediated organization of oncogenic chromatin state is a targetable vulnerability in leukemia

Ly Vu, Zhen Jin, Brenda Ma, Karen Chan, Diana Lin, Debajeet Ghosh, Amber Louwagie, Luke Saville, Joanne Liani Chandra, Yilin Liu, Zongmin Liu, Leo Escano, Sandra Spencer Miko, Se Wing Grace Cheng, Priscila Elias Ferreira Stricker, , Pieter R. Cullis

This study identifies PAN3-AS1 as an oncogenic lncRNA in AML, shows its role in chromatin organization, and demonstrates RNA-targeting LNP therapy to reduce leukemia burden.

bioRxiv · Aug 11, 2026 · PreprintCancer Biology